Compare XGN & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XGN | MAPS |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | United States |
| Employees | N/A | 449 |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 75.5M |
| IPO Year | 2014 | N/A |
| Metric | XGN | MAPS |
|---|---|---|
| Price | $5.35 | $0.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $8.86 | $2.61 |
| AVG Volume (30 Days) | 556.4K | ★ 7.7M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $13.00 | $6.17 |
| P/E Ratio | ★ N/A | $9.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $0.32 |
| 52 Week High | $12.23 | $1.36 |
| Indicator | XGN | MAPS |
|---|---|---|
| Relative Strength Index (RSI) | 77.83 | 33.93 |
| Support Level | $2.68 | $0.33 |
| Resistance Level | $6.75 | $0.75 |
| Average True Range (ATR) | 0.41 | 0.05 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 92.00 | 12.23 |
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.